This site is intended for healthcare professionals only

The Diabetic
Foot Journal


Share this article

Healing made possible in complicated diabetic foot ulcers — a case report using larval therapy

Sinead Casserly, Etaoin Donohoe, Najia Siddique, Diarmuid Smith
The authors presented a case of a difficult-to-heal neuropathic foot ulcer in a type 2 diabetic female. The ulcer was between her left fourth and fifth toes. Her X-ray and MRI foot confirmed the presence of osteomyelitis at the site. After initial hospitalisation, the patient was treated with antibiotics and a multidisciplinary approach. Numerous dressings were applied to the ulcer with little benefit. One of the difficulties in dressing application was the location of the ulcer in between the toes on the sole of the foot. Due to little progress over time, lower-limb amputation was considered. However, as a final option, bio-therapy in the form of larvae treatment was tried. The patient responded well to it and healthy granulation tissue with reduction in wound size became progressively evident. Finally, over a period of 5 months, the ulcer healed completely and the patient was back mobilising fully.

Diabetic foot disease is one of the most common and feared complications of diabetes. Foot ulceration affects 5% of patients with diabetes and precedes a lower-limb amputation in diabetes in 80% of cases. Prevention and healing of diabetic foot ulcers is, therefore, critical in preventing lower-limb amputations and maintaining quality of life for the patient (Ramsey et al, 1999).

Larval therapy is used worldwide to heal chronic and complicated wounds, including vascular, neuropathic and pressure ulcers, and also to treat trauma-related injuries, such as burns and surgical wounds. The following case report highlights the use of larvae therapy in a patient with a chronic non-healing diabetic foot ulcer.

Case history
A 61-year-old female with a 30-year history of type 2 diabetes on insulin presented to the diabetic foot clinic with an infected neuropathic intra-digital ulcer. The ulcer was between her left fourth and fifth toes with a surrounding cellulitis spreading up the left leg. Her diabetes had always been difficult to control and was complicated by diabetic proliferative retinopathy, renal impairment, neuropathy, hypertension and high cholesterol. Her HbA1c around the time of presentation was 78 mmol/mol (9.3%).

Investigations showed a normal white cell count of 6.4×109/L, neutrophils of 3.2/uL, raised erythrocyte sedimentation rate (ESR) of 40 and C-reactive protein (CRP) of 140 mg/L. Her deep wound swab was positive for Extended Spectrum Beta Lactamase (ESBL) and Proteus. An X-ray of the left foot showed marked swelling of the overlying soft tissues with bony resorption of the head and proximal shaft of left fourth and fifth metatarsals. Her MRI foot confirmed the presence of osteomyelitis in her left fourth and fifth toes. Her Ankle Brachial Pressure Index showed a value of 1.4 on the right and 0.95 on the left consistent with non-compressible vessels due to excessive vascular calcification. Toe Branchial Index of the right and left limbs were, however, both normal with values of 0.82 and 0.81, respectively.

Treatment consisted of offloading the foot, intravenous Piperacillin/Tazobactam for 6 weeks, improved blood glucose control and regular debridement of necrotic tissue. Numerous dressings were applied to the ulcer with little benefit. One of the difficulties in dressing application was the location of the ulcer in between the toes on the sole of the foot.

After 2 to 3 weeks, little progress was made and lower-limb amputation was being considered. However, as a final option, bio-therapy in the form of larvae treatment was tried. The larvae were ordered from the UK and, with the consent of the patient, the larvae were placed on the foot ulcer in a sterile BioBag® (BioMonde). A hydrocolloid dressing, which consisted of a combination of gel-forming polymers to help as an absorbent to manage wound exudates by swelling into a gel-like mass, was applied at the edge of the foot ulcer to prevent excoriation of the surrounding skin. The bio bag was then covered with a sterile saline-moistened gauze swab to prevent the larvae from becoming dehydrated and inactive. The dressings were checked daily to ensure that the larvae were still alive. One bio bag dressing was left in place for a maximum of up to 4 days. As the maggots finish secreting their proteolytic enzymes in up to 72 hours, the wound bed was closely reassessed at every dressing change for a change in colour of the eschar. The old dressing was removed if the larvae had finished secreting the enzymes.

Wound debris can harbour bacteria rendering it to a risk of infection. Therefore, the need for a next treatment cycle was determined regularly depending on the extent of the remaining necrotic tissue. Significant de-sloughing and heavy exudate around the ulcer were observed in between the treatment cycles. Due to the extensive nature of her foot ulcer, the patient required three sets of applications, which remains the average amount of applications at most treatment centres. During the following few weeks, the ulcer started to show a significant clinical improvement. Healthy granulation tissue and reduction in wound size became progressively evident during follow-up visits. Finally, over a period of 5 months, the ulcer healed completely and the patient was back mobilising fully. Photographs prior to and post application were taken and kept for records (Figure 1).

Achieving ulcer healing in diabetes is difficult. Most patients with complicated foot ulcers require an inpatient stay and in Ireland alone, the inpatient cost of treating a diabetic ulcer over 1 year was estimated at €23,500 per patient (Smith et al, 2004). Failure to treat can be catastrophic and lead to foot amputation. However the International Diabetes Federation has established that amputation risk can be decreased by 49% to 85% with the implementation of appropriate care strategies (International Diabetes Federation, 2012).

The management of a foot ulcer includes multidisciplinary input, intensive diabetes control, offloading, improving the vascular supply to the affected foot and ensuring the ulcer is not infected, regular debridement and allowing the tissue to heal in a sterile environment conducive to tissue healing and wound regeneration (Kavitha et al, 2014).

Larval therapy or bio surgery has been used to assist in wound debridement and healing for decades (Baer, 1931). However, it was not used to its full potential in the past. Clinical trial data and meta-analyses since 1990 have reported the efficacy and safety of larvae therapy in comparison with more conventional and invasive treatments, including surgery in the diabetic population (Mumcuoglu et al, 1998; Armstrong et al, 2005; Tian et al, 2013). It is, however, often used as a last resort treatment for wounds where conservative measures fail and surgery is not considered due to other medical co-morbidities.

Larvae are sterile maggots of the common green bottle fly, Lucilia sericata. They not only physically feed on the necrosed tissue, but they also exhibit a dual mechanical and secretory effect on the wound (Nigam et al, 2006). First of all their movement helps disintegrate the sloughed tissue. Secondly, the larvae secrete proteolytic enzymes, such as trypsin and chymotrypsin, to liquidise necrosed tissue, which they subsequently ingest (Choudhary et al, 2016).

Evidence also suggests that larval secretions are antimicrobial and, therefore, combat wound infections by substantial destruction of wound pathogens reducing the bioburden within the wound. Wound bacteria often aggregate to form a resistant layer known as a biofilm. This is extremely difficult to eradicate with antimicrobials or topical applications and, therefore, add to chronicity of the wound and prevent ulcer healing. Larval secretions have been shown to disrupt this pre-formed biofilm and preclude further formation (Sherman, 2014). The larvae also appear to have an effect on promoting fibroblast proliferation and collagen synthesis within the wound, which promote wound healing (Horobin et al, 2006). The effects of larval secretions on inflammatory mediators, such as neutrophil, moncocyte and macrophage function, have been investigated and it is now recognised that secretions from the larvae blunt the effects of these mediators and thus attenuate a chronic inflammatory response in the wound. The larval secretions have a particular effect on neutrophil function, not only reduce production and release of tissue damaging substances, such as elastase and hydrogen peroxide, but also inhibiting chemotaxis of neutrophils into the infected site (Horobin et al, 2006).

There has been a noticeable increase in the use of larvae therapy over recent few years (Strohal et al, 2013). This form of bio surgery has successfully been used to avoid lower-limb amputation in some patients with complicated and compromised diabetic foot ulcers (Sherman, 2009). Hence, it is now seen as a safe and effective treatment.

This case report demonstrates the holistic approach of a multidisciplinary team towards the management of a diabetic foot ulcer. Larva therapy allowed the skin to reepithelialise and heal, and reduced the length of the hospital admission. Scientific evidence supporting the efficacy and safety of larvae therapy is growing. However, there still exists the need to conduct large prospective clinical trials. This necessitates exploring the mechanisms and developing a complete understanding of this interesting wound-healing technique.


Armstrong DG, Salas P, Short B et al (2005) Maggot therapy in “lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days. J Am Podiatr Med Assoc 95(3): 254–7
Baer WS (1931) The treatment of chronic osteomyelitis with the maggot (larva of the blowfly). J Bone Joint Surg 13: 438–75
Choudhary V, Choudhary M, Pandey S et al (2016) Maggot debridement therapy as primary tool to treat chronic wound of animals. Vet World 9(4): 403–9
Horobin AJ, Shakesheff KM, Pritchard DI (2006) Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J Invest Dermatol 126(6): 1410–8
International Diabetes Federation (2012) Clinical Guidelines Task Force: Global Guidance for Type 2 Diabetes. International Diabetes Federation, Brussels. Available at: (accessed 20.02.2018)
Kavitha KV, Tiwari S, Purandare VB et al (2014) Choice of wound care in diabetic foot ulcer: a practical approach. World J Diabetes 5(4): 546–56
Mumcuoglu KY, Ingber A, Gilead L et al (1998) Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care 21(11): 2030–1
Nigam Y, Bexfield A, Thomas S, Ratcliffe NA (2006) Maggot therapy: the science and implication for CAM part II—maggots combat infection. Evid Based Complement Alternat Med 3(3): 303–8
Ramsey SD, Newton K, Blough D et al (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22(3): 382–7
Sherman RA (2009) Maggot Therapy Takes Us Back to the Future of Wound Care: New and Improved Maggot Therapy for the 21st Century. J Diabetes Sci Technol 3(2): 336–44
Sherman RA (2014) Mechanisms of maggot-induced wound healing: what do we know, and where do we go from here? Evid Based Complement Alternat Med. Volume 2014 Article ID 592419
Strohal R, Dissemond J, O’Brien J et al (2013) EWMA document: debridement. An updated overview and clarification of the principle role of debridement. J Wound Care 22(1): S1–52
Smith D, Cullen MJ, Nolan JJ (2004) The cost of managing diabetic foot ulceration in an Irish hospital. Ir J Med Sci 173(2): 89–92
Tian X, Liang XM, Song GM et al (2013) Maggot debridement therapy for the treatment of diabetic foot ulcers: a meta-analysis. J Wound Care 22(9): 462–9 

Related content
A good sense of EWMA
Understanding personality traits: could this help us support better foot self-care behaviours in people with diabetes?
Amputation inequalities across a large metropolitan area of England and effect of a ‘high-risk’ rather than ‘diabetes-only’ multidisciplinary approach to lower-limb wound care 2015/16 to 2021/22
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.